Pulmonary arterial hypertension after congenital heart defect correction: a call for timely diagnosis and careful risk stratification to improve outcomes
Mortality and morbidity are considerable in patients with PAH-CHDcor despite modern management. Regular, careful screening of all patients with repaired CHD is essential to ensure early diagnosis and risk stratification, with proactive evidence-based treatment to improve outcomes in this expanding population.
Authors
- Konstantinos Dimopoulos (ORCID: https://orcid.org/0000-0003-1300-0504)
- Andrew Constantine (ORCID: https://orcid.org/0000-0001-7899-463X)
- Chen Zhang (ORCID: https://orcid.org/0000-0002-8573-8236)
- Qiang Wang (ORCID: https://orcid.org/0000-0002-6049-1097)
- Hong Gu (ORCID: https://orcid.org/0000-0003-3744-2307)
- Qiangqiang Li (ORCID: https://orcid.org/0000-0002-2649-6775)
- Yuan He (ORCID: https://orcid.org/0000-0002-7282-8013)
Institutions
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Alabama at Birmingham (US)
- Royal Brompton Hospital (GB)
- Lung Institute (US)
- Beijing Anzhen Hospital (CN)
- Imperial College London (GB)
- University of Birmingham (GB)
Publication Details
- Journal
- European Heart Journal Open
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1093/ehjopen/oeaf172
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00